Ke Jiang

2 months ago | mdpi.com | Hui Wang |Kaichao Zhang |Ke Jiang |Xiaobin Zhang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jan 5, 2025 | mdpi.com | Ke Jiang

4.3. Discussion and Comparison of Pyrolysis Simulation Experiment ResultsTo verify the above discussion and hypothesis, semi-closed- and open-system pyrolysis simulation experiments were conducted on low-maturity shale samples from the Dalong Formation. The temperature of the pyrolysis experiments ranged from 350 °C to 600 °C, corresponding to the three hydrocarbon maturity stages: mature, high maturity, and overmature [42].

Sep 26, 2024 | dx.doi.org | Hao Gu |Ke Jiang |Fei Yu |Liying Wang

Functional Nanostructured Materials (including low-D carbon)September 26, 2024 Hao Gu Key Laboratory of Advanced Structural Materials, Ministry of Education & Advanced Institute of Materials Science, Changchun University of Technology, Changchun 130012, China State Key Laboratory of Luminescence and Applications, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun 130033, China * Ke Jiang State Key Laboratory of Luminescence and Applications,...

Aug 5, 2024 | dx.doi.org | Ke Jiang |Ling Zhang |Banglin Chen |Qiaomei Ke

May 30, 2024 | nature.com | Huan Zhang |Lu Tang |Ke Jiang

AbstractPost-translational modifications of proteins in malignant transformation and tumor maintenance of pancreatic ductal adenocarcinoma (PDAC) in the context of KRAS signaling remain poorly understood. Here, we use the KPC mouse model to examine the effect of palmitoylation on pancreatic cancer progression. ZDHHC20, upregulated by KRAS, is abnormally overexpressed and associated with poor prognosis in patients with pancreatic cancer.